The PRV Program cost taxpayers absolutely nothing--let me repeat: nothing--while at the same time helping to speed treatments and potential cures to pediatric rare disease patients who desperately need them.
Butterfield highlights the cost-effectiveness and benefits of the Pediatric PRV Program.
Share & report
More from G. K. Butterfield
Mr. Speaker, I yield 1 minute to the gentlewoman from Massachusetts (Ms. Clark), our Assistant Speaker.
Madam Speaker, at this time in the interest of time, I yield 30 seconds to the gentleman from Texas (Mr. Allred), my friend from Dallas, who represents the 32nd Congressional District.
Mr. Speaker, I yield 1 minute to the distinguished gentleman from Maryland (Mr. Raskin), who is a member of the coveted House Committee on House Administration.
The burden of proof is on the Member to prove that she is not guilty of the offense for which she is charged.
Other voices in this conversation
